MedPath
NMPA Approval

Avapritinib Tablets

国药准字HJ20210021

March 30, 2021

Drug Information

阿伐替尼片

泰吉华

片剂

300mg

化学药品

March 30, 2021

March 29, 2026

Company Information

Applicant Company

45 Sidney St, Cambridge, MA 02139 United States of America

Manufacturing Company

8 Orchard Place, Nottingham Business Park, Nottingham, Nottinghamshire NG8 6PX, UNITED KINGDOM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

阿伐替尼片 - NMPA 批准文号 | MedPath